- Home
- »
- Medical Devices
- »
-
Moist Wound Dressings Market Size Report, 2026-2033GVR Report cover
Moist Wound Dressings Market (2026 - 2033)
Size, Share & Trends Analysis Report By Product (Foam Dressings, Film Dressings, Hydrocolloid Dressings), By Application (Acute Wounds, Chronic Wounds), By End Use (Hospitals, Specialty Clinics, Home Healthcare), By Region, And Segment Forecasts
Market Size, 2025
$5.0BMarket Estimate, 2026
$5.2BMarket Forecast, 2033
$7.6BCAGR, 2026–2033
5.5%Moist Wound Dressings Market Summary
The global moist wound dressings market size was valued at USD 5.0 billion in 2025 and is projected to grow from USD 5.2 billion in 2026 to USD 7.6 billion by 2033, growing at a CAGR of 5.5% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 45.0% in 2025. Wound dressings have evolved from simple coverings to advanced products that deliver pharmaceutically active ingredients to accelerate healing and reduce pain and inflammation.
Key Market Trends & Insights
- By product: The foam dressing segment dominated the market, with a revenue share of approximately 25.0% in 2025.
- By application: The chronic wound segment held the largest market share of approximately 60.0% in 2025.
- By end use: The hospital segment held the largest revenue share of over 45.0% in 2025.
Regional Highlights
- Largest regional market: North America (45.0% revenue share, 2025)
- Fastest-growing regional market: Asia Pacific (highest CAGR, 2026-2033)
Market Size & Forecast
- Market size in 2025: USD 5.0 Billion
- Estimated market size in 2026: USD 5.2 Billion
- Projected market size by 2033: USD 7.6 Billion
- CAGR (2026-2033): 5.5%
Three ways to get this report
Buy it, customize it, or ask a question.Ask an Analyst
Analyst response in 1 business day
- AccessReport author, directly
- Reply timeWithin 1 working day
- No sales callDirect answer only
- FormatEmail reply
- CostFree, no cost
Get the Full Report
What the study covers
- FormatsPDF · Excel · Dashboard
- Timeline2026–2033 annual, 2025 base
- Coverage20+ countries, 5 regions
- Companies10+ key players profiled
Customize the Report
20% free customization
- IncludeCountries, segments, points
- TailorTo your product definition
- ExtendDeeper competitor detail
- OrA fully bespoke study
- Turnaround5–10 working days
Wound care is essential to enhance the healing process and minimize the risk of associated infections. The rising incidence of diabetic pressure, venous stasis, and foot ulcers is among the key factors driving the market growth.The launch of novel therapies for wound healing, such as electromagnetic therapy, electrical stimulation, nanotechnology, and silver- and other-combination dressings, is boosting market growth. These advancements improve wound care, thereby increasing product adoption. A major market advancement is the ability of these dressings to regulate moisture at the wound site, which aids tissue regeneration and reduces infection and pain. Advanced products facilitate wound protection, gas exchange, antibacterial protection, thermal insulation, and exudate absorption, thereby boosting market growth.
Source: Grand View Research, IR Documents, Primary Interviews, Paid DatabasesTo learn more about this report,Download Free Sample Report
During the pandemic, the wound treatment centers in Italy managed a major reduction in the frequency of hospital admissions, since just urgencies, like extreme infections or wound hemorrhagic complexities, were permitted in the hospitals. The launch of novel therapies, such as electromagnetic therapy, electrical stimulation, nanotechnology, and the use of silver and other combination dressings are boosting market growth. These advancements ensure better wound care and thus increase product adoption. A major advancement in the market includes the ability of these dressings to regulate moisture at the wound site, which aids in the regeneration of tissue and reduces infection and pain. Advanced products facilitate wound protection, gas exchange, antibacterial protection, thermal insulation, and exudate absorption, thereby boosting market growth.
In addition, the rising incidence of burn injuries is expected to drive demand for moist wound dressings. According to the WHO, every year, approximately 180,000 deaths occur due to burn injuries. Moreover, the growing geriatric population worldwide is expected to support market expansion. According to WHO estimates, the global geriatric population (aged 60 years and above) is expected to reach about 2 billion by 2050. This age group is susceptible to injuries and chronic wounds, such as venous leg ulcers and pressure ulcers, which are expected to spur market growth in the years to come. Emerging regions, such as Southeast Asia, are expected to experience significant growth in burn injury rates. Growing disposable income, rising awareness regarding these dressing products, and the availability of better-quality products in such regions are also contributing to market growth.
Market Dynamics
Advancements in wound treatment and dressings are primarily driving demand for moist wound dressings. Hydrocolloids, foam, hydrogel, and alginate dressings help tissue regeneration and expedite wound healing. Besides, a high incidence rate among the aging and diabetic population is also supporting market growth. However, the high cost of treatments and products may hinder the market. However, continuous innovation in moist wound dressings is expected to create new growth opportunities for the market.
The growth of the moist wound dressings market is primarily driven by the rising prevalence of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers. According to the National Library of Medicine, approximately 6.5 million people in the U.S. suffer from chronic wounds. At the global level, approximately 1-2% of the global population suffers from some kind of chronic wounds. The increasing aging population, along with the growing incidence of diabetes and obesity, has led to a higher number of patients requiring advanced wound care solutions. Moist wound dressings are widely preferred as they create an optimal healing environment that promotes faster tissue regeneration while reducing the risk of infection and scarring. Their proven effectiveness in managing both acute and chronic wounds has significantly increased their adoption across healthcare settings.
Growing awareness among healthcare professionals and patients regarding the benefits of advanced wound care products is supporting market expansion. Continuous technological advancements in dressing materials, including hydrocolloid, foam, hydrogel, and alginate dressings, have further enhanced treatment results and expanded their clinical applications. Additionally, rising healthcare expenditures and increased access to modern wound management services are driving sustained growth in the moist wound dressings market.
Despite the growing adoption of advanced wound care products, several factors continue to restrain the growth of the moist wound dressings market. One of the primary challenges is the relatively high cost of advanced wound dressings compared to traditional wound care products. This can limit their adoption, particularly in cost-sensitive regions of Asia and Latin America. The issue is further compounded by limited reimbursement coverage in certain countries, increasing the financial burden on patients and healthcare providers.
In addition, inadequate training and awareness of the proper application and benefits of advanced wound dressings may hinder their widespread use. Many healthcare professionals continue to rely on conventional wound care methods due to their lower cost and familiarity. The availability of affordable alternative treatment options also poses a challenge to market expansion. Furthermore, some patients may experience skin irritation or allergic reactions to certain dressing materials, which can negatively affect patient compliance and product acceptance. Collectively, these factors may constrain the growth potential of the moist wound dressings market over the forecast period.
The moist wound dressings market presents significant growth opportunities, driven by the increasing demand for advanced wound management solutions across both developed and emerging economies. The growing awareness of the benefits of moist wound healing, including faster recovery, improved tissue regeneration, and reduced infection risk, is driving the adoption of advanced dressing products. These products help in maintaining an optimal wound-healing environment, resulting in faster tissue regeneration.
Continuous innovation in wound care technologies is creating new avenues for market growth. The development of advanced products, such as antimicrobial, bioactive, and smart wound dressings with monitoring capabilities, is offering better treatment results and expanding clinical applications. Improvements in healthcare infrastructure and greater access to specialized wound care services in developing countries are also supporting market expansion. Furthermore, the growing shift from inpatient care to home healthcare and outpatient settings is generating demand for convenient, cost-effective, and easy-to-use wound management solutions, creating substantial opportunities for manufacturers operating in the moist wound dressings market.
Product Insights
The foam dressings segment accounted for the largest market share of 23.4% in 2022 due to the soft and comfortable feel of these dressings. Moreover, they help prevent and stop exudation from burn injuries, which is also driving the segment growth. Due to their highly absorbent nature, these dressings can be changed after around 3-4 days and are used for wounds with heavy exudation without the complication of maceration. According to the American Burn Association, approximately 450,000 patients are hospitalized due to burns each year and the risk of infection is higher in these patients. These dressings are recommended for chronic wounds like pressure and diabetic foot ulcers and burn injuries as they help create and maintain a moist environment, which facilitates a faster healing process.
The hydrocolloid dressings segment is expected to grow at the fastest CAGR of 6.02% during the forecast period. These dressings create a moist environment around the wound that helps complement the healing process. Hydrocolloid dressings also provide an occlusive barrier over the wound, protecting it from external contaminants, bacteria, and other pathogens. These dressings are flexible and conform well to the body contours, making them suitable for use in various anatomical locations. They can be easily applied to areas with irregular surfaces, such as elbows, knees, and heels.
Analyst Perspective
The growth of moist wound dressings market is supported by the rising prevalence of chronic wounds and the increasing global burden of diabetes, obesity, and age-related health conditions. Advanced wound care products are gaining wider acceptance due to their ability to accelerate healing, reduce infection risks, and improve patient outcomes. Although high product costs and limited reimbursement coverage remain key challenges, ongoing technological advancements and growing awareness of advanced wound management are expected to support market expansion.
Product Insights
The foam dressings segment accounted for the largest market share, over 23.0% in 2025, due to their soft, comfortable feel. This type of dressing helps prevent and stop exudation from burn injuries. Due to their highly absorbent nature, these dressings can be changed after around 3-4 days and are used for wounds with heavy exudation without the complication of maceration. According to the American Burn Association, approximately 450,000 burn-affected patients are hospitalized each year, and the risk of infection is higher in these patients. These dressings are recommended for chronic wounds, such as pressure ulcers, diabetic foot ulcers, and burn injuries, as they help create and maintain a moist environment, which facilitates faster healing.
The hydrocolloid dressings segment is expected to grow at the fastest CAGR of over 6.0% during the forecast period. These dressings create a moist environment around the wound, which helps support the healing process. Hydrocolloid dressings also provide an occlusive barrier over the wound, protecting it from external contaminants, bacteria, and other pathogens. These dressings are flexible and conform well to the body contours, making them suitable for use in various anatomical locations. They can be easily applied to areas with irregular surfaces, such as elbows, knees, and heels.
Application Insights
The segment of chronic wounds held the largest revenue share of approximately 60.0% in 2025. The increase in the number of diabetic foot ulcers, pressure ulcers, and venous leg ulcers has become the major reason behind the growth of the segment, as these wounds need special care. Based on the statistics provided by the IDF, approximately 537 billion people suffer from diabetes around the world. Also, diabetes complications have been on the rise all around the globe. For instance, a 2024 report published in Frontiers in Clinical Diabetes and Healthcare stated that the global prevalence of diabetic foot ulcers among patients with diabetes is approximately 6.3%. Also, according to the article in Diabetes Care, between 19% and 34% of patients suffering from diabetes would develop diabetic foot ulcers. Therefore, the increasing prevalence of chronic wounds, together with increased healthcare expenditure and use of advanced wound care products, is fueling the demand for moist wound dressings in the industry. The lifetime risk of diabetic foot ulcers is projected to be 15% - 20%. Therefore, as a result of the above-mentioned factors, the chronic wound segment is expected to dominate the market even during the forecast period.
The acute wounds segment is expected to grow at the fastest during the forecast period due to the increasing prevalence of the disease and related complications. With the availability of advanced wound-dressing products, such ulcers can be treated and healed quickly, reducing hospital stays & overall costs.
End-use Insights
Based on end-use, the market can be further categorized into hospitals, specialty clinics, home healthcare, and others. The hospitals segment dominated the global industry in 2025, accounting for more than 45.0% of overall revenue. This growth can be attributed to the rising number of surgeries performed in these settings.
The segment's growth is also driven by the rising prevalence of chronic diseases and wounds. In addition, the high prevalence of hospital-acquired infections (HAIs) is anticipated to drive the segment growth. The home care segment is expected to register considerable growth over the forecast period, driven by increasing awareness.
Regional Insights
North America dominated the market, accounting for the largest revenue share of more than 45.0% in 2025, owing to the presence of the target population and increased patient awareness. The market is expected to expand further due to the increasing prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, in the region. According to the CDC, approximately 2.5 billion patients develop pressure ulcers each year. The easy availability of products, enabled by major market players and their wide distribution networks, will also contribute to regional market growth.
To learn more about this report,Download Free Sample Report
Asia Pacific Moist Wound Dressing Market Trends
The Asia Pacific regional market is expected to grow at the fastest CAGR of more than 6.0% during the forecast period. The region is home to a significant population with highly populated countries, including India, China, and Indonesia. Many people in the region suffer from chronic wounds caused by diabetes. Growing awareness of wound treatment and the increasing availability of moist wound dressings are driving market growth. In addition, the region is also witnessing significant increases in healthcare expenditure, government support, and investment in research and development.
Key Moist Wound Dressing Company Insights
The market is highly competitive, and players are undertaking product launches, approvals, strategic acquisitions, and innovations to gain a competitive edge. New products launched in one of the most preferred strategic developments undertaken by these companies. For instance, in September 2024, Solventum Corporation announced the launch of its vacuum-assisted closure peel and place dressing, an all-in-one advanced wound dressing designed for negative pressure wound therapy. The new launch will extend the company’s existing infection prevention and wound care product portfolio.
Key Moist Wound Dressing Companies
The following key companies have been profiled for this study on the moist wound dressing market.
-
Coloplast A/S
-
Medline Industries, Inc.
-
Smith & Nephew
-
Convatec, Inc.
-
Systagenix
-
Derma Sciences, Inc.
-
Cardinal Health
-
Acelity
-
3M
-
B. Braun Medical Inc.
Recent Developments
-
In March 2026, Smith and Nephew introduced its new-generation Allevyn Complete Care Foam Dressing, which is aimed at improving wound management and prevention of pressure injuries. This multi-layer dressing helps improve fluid management and minimize the risk of leakage, while creating a perfect moist environment for wound healing.
-
In July 2025, Regulatory approvals were granted across the market for the use of Convatec's new hydrofiber dressing called the AQUACEL ConvaFiber hydrofiber dressing in several leading regions, such as the U.S., the UK, the European Union, and Australia. The dressing will be used to treat chronic and acute wounds, including diabetic foot ulcers, venous leg ulcers, and pressure injuries.
Moist Wound Dressings Market Report Scope
Report Attribute
Details
Market size in 2025
USD 5.0 billion
Estimated market size in 2026
USD 5.2 billion
Projected market size by 2033
USD 7.6 billion
Growth rate
CAGR of 5.5% from 2026 to 2033
Base year for estimation
2025
Actual data
2021 - 2024
Forecast period
2026 - 2033
Quantitative units
Revenue in USD billion, and CAGR from 2026 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Product, application, end-use, region
Regional Scope
North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country scope
U.S.; Canada; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; Saudi Arabia; South Africa; UAE; Kuwait
Key companies profiled
Coloplast A/S; Medline Industries, Inc.; Smith & Nephew; Convatec Inc.; Systagenix; Derma Science, Inc.; Cardinal Health; Acelity; 3M; B. Braun Medical Inc.
Customization scope
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail of customized purchase options to meet your exact research needs. Explore purchase options
Global Moist Wound Dressings Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global moist wound dressings market report on the basis of product, application, end-use, and region:
To learn more about this report,Download Free Sample Report
-
Product Outlook (Revenue, USD Billion, 2021 - 2033)
-
Foam Dressings
-
Hydrocolloid Dressings
-
Film Dressings
-
Alginate Dressings
-
Hydrogel Dressings
-
Collagen Dressings
-
Other Advanced Dressings
-
-
Application Outlook (Revenue, USD Billion, 2021 - 2033)
-
Acute Wounds
-
Surgical & Traumatic Wounds
-
Burns
-
-
Chronic Wounds
-
Diabetic Foot Ulcers
-
Pressure Ulcers
-
Venous Leg Ulcers
-
Other Chronic Wounds
-
-
-
End-use Outlook (Revenue, USD Billion, 2021 - 2033)
-
Hospitals
-
Specialty Clinics
-
Home Healthcare
-
Others
-
-
Regional Outlook (Revenue, USD Billion, 2021 - 2033)
-
North America
-
U.S.
-
Canada
-
-
Europe
-
UK
-
Germany
-
France
-
Italy
-
Spain
-
Sweden
-
Norway
-
Denmark
-
-
Asia Pacific
-
China
-
Japan
-
India
-
Australia
-
Thailand
-
South Korea
-
-
Latin America
-
Brazil
-
Mexico
-
Argentina
-
-
Middle East & Africa
-
Saudi Arabia
-
South Africa
-
UAE
-
Kuwait
-
-
Frequently Asked Questions About This Report
Key players include Coloplast A/S; Medline Industries, Inc.; Smith & Nephew; Convatech Inc.; Systagenix; Derma Science, Inc.; Cardinal Health; Acelity; 3M; B. Braun Medical Inc.
North America dominated with a 45.0% revenue share in 2025.
The global moist wound dressings market size was valued at USD 5.0 billion in 2025 and is estimated at USD 5.2 billion for 2026.
The global moist wound dressings market is expected to grow at a CAGR of 5.5% from 2026 to 2033, reaching USD 7.6 billion.
Chronic wound dominated the moist wound dressings market with a share of 60.0% in 2025.
About the Author(s)
Medical Devices Research Team
Healthcare · Medical DevicesThis report was authored by the medical devices research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the medical devices segment of the healthcare industry. All findings are based on proprietary healthcare databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.
Last Updated:
Speak to Analyst
Customize this report to your needs - add regions, segments, or data points, with 20% free customization.
Or view our licence options:
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.